跳至主要内容
临床试验/NL-OMON40821
NL-OMON40821已完成2 期

68Ga-NODAGA-exendin-4 PET/CT in patients with AHH - a prospective comparative evaluation of preoperative imaging - 68Ga-NODAGA-exendin-4 PET/CT in patients with AHH

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Biochemically proven endogenous hyperinsulinemic hypoglycemia: neuroglycopenic symptoms in the fasting state with low plasma glucose, inappropriately high serum insulin and C-peptide concentrations
  • Signed informed consent
  • Standard imaging not older than 8 weeks. This includes a triple-phase CT or MRI, somatostatin receptor imaging (68Ga-DOTATOC, 68Ga-DOTATATE or 111In-DTPA-octreotide SPECT/CT) and endocopic ultrasound (EUS).

排除标准

  • Breast feeding
  • Pregnancy or the wish to become pregnant within 6 months
  • Calculated creatinine clearance below 40ml/min
  • Evidence of other malignancy than insulin producing tumors in conventional imaging (suspicious liver, bone and lung lesions)
  • Age < 18 years
  • No signed informed consent

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验